Cutaneous reactions to trimethoprim-sulfamethoxazole in African patients with the acquired immunodeficiency syndrome
Colebunders, R.; Izaley, L.; Bila, K.; Kabumpangi, K.; Melameka, N.; Francis, H.; Curran, J.W.; Ryder, R.; Piot, P.
Annals of Internal Medicine 107(4): 599-600
1987
ISSN/ISBN: 0003-4819 PMID: 2957947 DOI: 10.7326/0003-4819-107-4-599_2Document Number: 359275
Document emailed within 0-6 h
Related Documents
García Aguado, C.; Martínez, R.; Laguna, F.; González Lahoz, J.M. 1989: Skin reactions to trimethoprim-sulfamethoxazole in Spanish patients with AIDS Enfermedades Infecciosas y Microbiologia Clinica 7(3): 177Rosenberg, J.D.; Scheinfeld, N.S. 2003: Cutaneous histoplasmosis in patients with acquired immunodeficiency syndrome Cutis 72(6): 439-445
Tsuchie, H.; Kawatani, T.; Nakayama, E.; Matsui, T.; Kurimura, T.; Hinuma, Y. 1985: Distribution of the level of antibody to acquired immunodeficiency syndrome associated virus in sera from acquired immunodeficiency syndrome related complex and japanese hemophiliacs infected with acquired immunodeficiency syndrome associated virus Microbiology and Immunology 29(11): 1083-1088
Gelanew, T.; Hurissa, Z.; Diro, E.; Kassahun, A.; Kuhls, K.; Schönian, G.; Hailu, A. 2011: Disseminated cutaneous leishmaniasis resembling post-kala-azar dermal leishmaniasis caused by Leishmania donovani in three patients co-infected with visceral leishmaniasis and human immunodeficiency virus/acquired immunodeficiency syndrome in Ethiopia American Journal of Tropical Medicine and Hygiene 84(6): 906-912
Ambrus, J.L.; Poiesz, B.J.; Lillie, M.A.; Stadler, I.; Di Berardino, L.A.; Chadha, K.C. 1989: Interferon and interferon inhibitor levels in patients infected with varicella-zoster virus, acquired immunodeficiency syndrome, acquired immunodeficiency syndrome-related complex, or Kaposi's sarcoma, and in normal individuals American Journal of Medicine 87(4): 405-407
Crumpacker, C.; Heagy, W.; Bubley, G.; Monroe, J.E.; Finberg, R.; Hussey, S.; Schnipper, L.; Lucey, D.; Lee, T.H.; McLane, M.F. 1987: Ribavirin treatment of the acquired immunodeficiency syndrome (AIDS) and the acquired-immunodeficiency-syndrome-related complex (ARC). A phase 1 study shows transient clinical improvement associated with suppression of the human immunodeficiency virus and enhanced lymphocyte proliferation Annals of Internal Medicine 107(5): 664-674
Kornaszewski, W.; Kornaszewska, M.; Skotnicki, A.B. 1986: Acquired immunodeficiency syndrome (AIDS) in the African environment Postepy Higieny i Medycyny Doswiadczalnej 40(3): 331-346
Borek, E.; Sharma, O.K.; Buschman, F.L.; Cohn, D.L.; Penley, K.A.; Judson, F.N.; Dobozin, B.S.; Horsburgh, C.R.; Kirkpatrick, C.H. 1986: Altered excretion of modified nucleosides and beta-aminoisobutyric acid in subjects with acquired immunodeficiency syndrome or at risk for acquired immunodeficiency syndrome Cancer Research 46(5): 2557-2561
Ndiaye, P.B.; Develoux, M.; Dieng, M.T.; Huerre, M. 1996: Diffuse cutaneous leishmaniasis and acquired immunodeficiency syndrome in a Senegalese patient Bulletin de la Societe de Pathologie Exotique 89(4): 282-286
Nogueira-Castañon, M.C.; Pereira, C.A.; Furtado, T. 1996: Unusual association of American cutaneous leishmaniasis and acquired immunodeficiency syndrome International Journal of Dermatology 35(4): 295-297
Gumbo, T.; Kadzirange, G.; Mielke, J.; Gangaidzo, I.T.; Hakim, J.G. 2002: Cryptococcus neoformans meningoencephalitis in African children with acquired immunodeficiency syndrome Pediatric Infectious Disease Journal 21(1): 54-56
Feldman, W.; Johnson, D.M.; Newberry, P.; Weldon, A.; Naidoo, S. 1975: Comparison of trimethoprim-sulfamethoxazole with sulfamethoxazole in urinary tract infections of children Canadian Medical Association Journal 112(13 Spec No): 19-21
Silverberg, J.I.; Votava, H.J.; Smith, B.L. 2012: Antiphospholipid antibody syndrome secondary to trimethoprim/sulfamethoxazole Journal of Drugs in Dermatology: Jdd 11(9): 1117-1118
Lemieux, G. 1974: Trimethoprim-sulfamethoxazole compared with sulfamethoxazole in urinary tract infection Canadian Medical Association Journal 110(8): 910-912
Yao, F.; Behling, C.A.; Saab, S.; Li, S.; Hart, M.; Lyche, K.D. 1997: Trimethoprim-sulfamethoxazole-induced vanishing bile duct syndrome American Journal of Gastroenterology 92(1): 167-169
Männistö, P.T. 1976: Comparison of oxolinic acid, trimethoprim, and trimethoprim-sulfamethoxazole in the treatment and long-term control of urinary tract infection Current Therapeutic Research 20(5): 645-654
DuPont, H.L.; Galindo, E.; Evans, D.G.; Cabada, F.J.; Sullivan, P.; Evans, D.J. 1983: Prevention of travelers' diarrhea with trimethoprim-sulfamethoxazole and trimethoprim alone Gastroenterology 84(1): 75-80
Ndakotsu, M.A.; Salawu, L.; Durosinmi, M.A. 2009: Lupus anticoagulant in Nigerian patients living with human immunodeficiency virus/acquired immunodeficiency syndrome Journal of Microbiology Immunology and Infection 42(1): 69-73
Wen, Y.; Li, C.; Pei, J.; Bai, J.; Yang, X.; Duan, K. 2014: The incidence of oral candidiasis in patients with human immunodeficiency virus infection/acquired immunodeficiency syndrome from Yunnan, China Zhonghua Kou Qiang Yi Xue Za Zhi 49(8): 454-458
Budhachandra, Y.; Ramesh, K.; Sumitra, G. 2007: Personality profile among Human Immunodeficiency Virus (HIV) positives and Acquired Immunodeficiency Syndrome (AIDS) patients of injecting drug users Kathmandu University Medical Journal 5(1): 38-41